v3.24.1.1.u2
Cover Page - shares
9 Months Ended
Mar. 31, 2024
May 09, 2024
Cover [Abstract]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Focus Mar. 31, 2024  
Document Transition Report false  
Entity File Number 001-35300  
Entity Registrant Name UBIQUITI INC.  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 32-0097377  
Entity Address, Address Line One 685 Third Avenue  
Entity Address, Address Line Two 27th Floor  
Entity Address, City or Town New York  
Entity Address, State or Province NY  
Entity Address, Postal Zip Code 10017  
City Area Code 646  
Local Phone Number 780-7958  
Title of 12(b) Security Common Stock, $0.001 par value per share  
Trading Symbol UI  
Security Exchange Name NYSE  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Large Accelerated Filer  
Entity Small Business false  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   60,461,405
Amendment Flag false  
Document Fiscal Year Focus 2024  
Document Fiscal Period Focus Q3  
Entity Central Index Key 0001511737  
Current Fiscal Year End Date --06-30  
v3.24.1.1.u2
Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2024
Jun. 30, 2023
Current assets:    
Cash and cash equivalents $ 102,487 $ 114,826
Investments — short-term 8 109
Accounts receivable, net of allowance for doubtful accounts of $232 and $92 at March 31, 2024 and June 30, 2023, respectively 187,564 167,787
Inventories 533,529 737,121
Vendor deposits 150,161 125,227
Prepaid expenses and other current assets 27,063 21,974
Total current assets 1,000,812 1,167,044
Property and equipment, net 82,205 86,845
Operating lease right-of-use assets, net 48,396 57,485
Deferred tax assets 23,021 23,701
Other long-term assets 69,350 71,324
Total assets 1,223,784 1,406,399
Current liabilities:    
Accounts payable 65,305 154,157
Income taxes payable 9,197 19,309
Debt — short-term 36,508 36,508
Other current liabilities 142,518 141,845
Total current liabilities 253,528 351,819
Income taxes payable — long-term 56,527 74,880
Operating lease liabilities — long-term 37,494 46,052
Debt — long-term 839,005 1,041,381
Deferred tax liability — long-term 226 226
Other long-term liabilities 11,131 7,774
Total liabilities 1,197,911 1,522,132
Commitments and Contingencies
Stockholders’ equity (deficit):    
Preferred stock—$0.001 par value; 50,000,000 shares authorized; none issued 0 0
Common stock—$0.001 par value; 500,000,000 shares authorized: 60,448,287 and 60,448,287 and 60,441,896 issued and outstanding as of March 31, 2024 and June 30, 2023, respectively 60 60
Additional paid–in capital 8,985 4,721
Retained earnings (deficit) 16,828 (120,514)
Total stockholders’ equity (deficit) 25,873 (115,733)
Total liabilities and stockholders’ equity (deficit) $ 1,223,784 $ 1,406,399
v3.24.1.1.u2
Consolidated Balance Sheets (Parenthetical) - USD ($)
$ in Thousands
Mar. 31, 2024
Jun. 30, 2023
Statement of Financial Position [Abstract]    
Allowance for doubtful accounts receivable $ 232 $ 92
Preferred stock, par value (in dollars per share) $ 0.001 $ 0.001
Preferred stock, shares authorized (in shares) 50,000,000 50,000,000
Preferred stock, shares issued (in shares) 0 0
Common stock, par value (in dollars per share) $ 0.001 $ 0.001
Common stock, shares authorized (in shares) 500,000,000 500,000,000
Common stock, issued (in shares) 60,461,405 60,441,896
Common stock, shares outstanding (in shares) 60,461,405 60,441,896
v3.24.1.1.u2
Consolidated Statements of Operations and Comprehensive Income - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Mar. 31, 2024
Mar. 31, 2023
Income Statement [Abstract]        
Revenues $ 492,997 $ 457,773 $ 1,421,029 $ 1,449,427
Cost of revenues 318,897 269,297 885,407 892,023
Gross profit 174,100 188,476 535,622 557,404
Operating expenses:        
Research and development 42,498 38,210 115,692 104,633
Sales, general and administrative 20,379 16,741 59,302 52,080
Total operating expenses 62,877 54,951 174,994 156,713
Income from operations 111,223 133,525 360,628 400,691
Interest expense and other, net 18,870 16,497 58,356 38,421
Income before income taxes 92,353 117,028 302,272 362,270
Provision for income taxes 16,063 18,451 56,116 58,306
Net income 76,290 98,577 246,156 303,964
Comprehensive income $ 76,290 $ 98,577 $ 246,156 $ 303,964
Net income per share of common stock:        
Basic (in dollar per share) $ 1.26 $ 1.63 $ 4.07 $ 5.03
Diluted (in dollar per share) $ 1.26 $ 1.63 $ 4.07 $ 5.03
Weighted average shares used in computing net income per share of common stock:        
Basic (in dollar per shares) 60,461 60,441 60,452 60,432
Diluted (in dollar per shares) 60,463 60,455 60,455 60,451
v3.24.1.1.u2
Consolidated Statements of Stockholders' Equity (Deficit) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Retained Earnings (Deficit)
Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Jun. 30, 2022   60,420,525      
Beginning balance at Jun. 30, 2022 $ (382,876) $ 60 $ 650 $ (383,112) $ (474)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net Income 93,182     93,182  
Other comprehensive (loss) (49)       (49)
Stock options exercised (in shares)   2,112      
Stock options exercised 23   23    
Restricted stock units issued, net of tax withholdings (in shares)   6,174      
Restricted stock units issued, net of tax withholdings (544)   (544)    
Share-based compensation expense 1,048   1,048    
Dividends paid on Common Stock (36,256)     (36,256)  
Ending balance (in shares) at Sep. 30, 2022   60,428,811      
Ending balance at Sep. 30, 2022 (325,472) $ 60 1,177 (326,186) (523)
Beginning balance (in shares) at Jun. 30, 2022   60,420,525      
Beginning balance at Jun. 30, 2022 (382,876) $ 60 650 (383,112) (474)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net Income 303,964        
Ending balance (in shares) at Mar. 31, 2023   60,441,733      
Ending balance at Mar. 31, 2023 (184,475) $ 60 3,391 (187,926) 0
Beginning balance (in shares) at Sep. 30, 2022   60,428,811      
Beginning balance at Sep. 30, 2022 (325,472) $ 60 1,177 (326,186) (523)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net Income 112,205     112,205  
Restricted stock units issued, net of tax withholdings (in shares)   2,147      
Restricted stock units issued, net of tax withholdings (50)   (50)    
Share-based compensation expense 1,101   1,101    
Dividends paid on Common Stock (36,257)     (36,257)  
Reclassification adjustment for loss on investments included in net income 523       523
Ending balance (in shares) at Dec. 31, 2022   60,430,958      
Ending balance at Dec. 31, 2022 (247,950) $ 60 2,228 (250,238) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net Income 98,577     98,577  
Restricted stock units issued, net of tax withholdings (in shares)   10,775      
Restricted stock units issued, net of tax withholdings (83)   (83)    
Share-based compensation expense 1,246   1,246    
Dividends paid on Common Stock (36,265)     (36,265)  
Ending balance (in shares) at Mar. 31, 2023   60,441,733      
Ending balance at Mar. 31, 2023 $ (184,475) $ 60 3,391 (187,926) $ 0
Beginning balance (in shares) at Jun. 30, 2023 60,441,896 60,441,896      
Beginning balance at Jun. 30, 2023 $ (115,733) $ 60 4,721 (120,514)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net Income 87,750     87,750  
Restricted stock units issued, net of tax withholdings (in shares)   5,660      
Restricted stock units issued, net of tax withholdings (313)   (313)    
Share-based compensation expense 1,500   1,500    
Dividends paid on Common Stock (36,268)     (36,268)  
Ending balance (in shares) at Sep. 30, 2023   60,447,556      
Ending balance at Sep. 30, 2023 $ (63,064) $ 60 5,908 (69,032)  
Beginning balance (in shares) at Jun. 30, 2023 60,441,896 60,441,896      
Beginning balance at Jun. 30, 2023 $ (115,733) $ 60 4,721 (120,514)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net Income $ 246,156        
Ending balance (in shares) at Mar. 31, 2024 60,461,405 60,461,405      
Ending balance at Mar. 31, 2024 $ 25,873 $ 60 8,985 16,828  
Beginning balance (in shares) at Sep. 30, 2023   60,447,556      
Beginning balance at Sep. 30, 2023 (63,064) $ 60 5,908 (69,032)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net Income 82,116     82,116  
Restricted stock units issued, net of tax withholdings (in shares)   731      
Restricted stock units issued, net of tax withholdings (11)   (11)    
Share-based compensation expense 1,506   1,506    
Dividends paid on Common Stock (36,269)     (36,269)  
Ending balance (in shares) at Dec. 31, 2023   60,448,287      
Ending balance at Dec. 31, 2023 (15,722) $ 60 7,403 (23,185)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net Income 76,290     76,290  
Restricted stock units issued, net of tax withholdings (in shares)   13,118      
Restricted stock units issued, net of tax withholdings (82)   (82)    
Share-based compensation expense 1,664   1,664    
Dividends paid on Common Stock $ (36,277)     (36,277)  
Ending balance (in shares) at Mar. 31, 2024 60,461,405 60,461,405      
Ending balance at Mar. 31, 2024 $ 25,873 $ 60 $ 8,985 $ 16,828  
v3.24.1.1.u2
Consolidated Statements of Stockholders' Equity (Deficit) (Parenthetical) - $ / shares
3 Months Ended
Mar. 31, 2024
Dec. 31, 2023
Sep. 30, 2023
Mar. 31, 2023
Dec. 31, 2022
Sep. 30, 2022
Statement of Stockholders' Equity [Abstract]            
Dividends paid on Common Stock (in dollars per share) $ 0.6 $ 0.6 $ 0.6 $ 0.6 $ 0.6 $ 0.6
v3.24.1.1.u2
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
9 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Cash Flows from Operating Activities:    
Net income $ 246,156 $ 303,964
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 14,711 12,164
Amortization of debt issuance costs 1,296 979
Non-cash lease expense 202 325
Provision for inventory obsolescence 21,668 8,142
Provision for loss on vendor deposits 16,732 (2,419)
Share-based compensation 4,671 3,394
Provisions for doubtful accounts 140 14
Deferred taxes 680 135
Provision for sales returns (312) 62
Other, net 101 1,105
Changes in operating assets and liabilities:    
Accounts receivable (19,917) (26,746)
Inventories 181,717 (489,463)
Vendor deposits (41,666) (5,045)
Prepaid expenses and other assets (4,805) (8,695)
Accounts payable (87,671) 74,827
Income taxes payable (28,464) (28,742)
Deferred revenues 3,235 (2,561)
Accrued and other liabilities 1,641 (1,312)
Net cash provided by (used in) operating activities 310,115 (159,872)
Cash Flows from Investing Activities:    
Purchase of property and equipment and other long-term assets (10,109) (15,650)
Net cash used in investing activities (10,109) (15,650)
Cash Flows from Financing Activities:    
Payment of common stock cash dividends (108,814) (108,778)
Proceeds from exercise of stock options 0 23
Tax withholdings related to net share settlements of restricted stock units (406) (677)
Net cash (used in) provided by financing activities (312,345) 191,818
Net (decrease) increase in cash and cash equivalents (12,339) 16,296
Cash and cash equivalents at beginning of period 114,826 136,224
Cash and cash equivalents at end of period 102,487 152,520
Supplemental Disclosure of Cash Flow Information:    
Income taxes paid, net of refunds 92,480 87,315
Interest paid 59,589 34,241
Non-Cash Investing and Financing Activities:    
Right-of-use asset recognized 2,250 5,814
Unpaid property and equipment and other long-term assets 94 1,097
Revolving credit facility    
Cash Flows from Financing Activities:    
Proceeds from borrowing under the credit facility- Revolver 0 380,000
Repayments of debt (175,000) (60,000)
Term Loan    
Cash Flows from Financing Activities:    
Repayments of debt $ (28,125) $ (18,750)
v3.24.1.1.u2
BUSINESS AND BASIS OF PRESENTATION
9 Months Ended
Mar. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
BUSINESS AND BASIS OF PRESENTATION BUSINESS AND BASIS OF PRESENTATION
Business— Ubiquiti Inc. and its wholly owned subsidiaries (collectively, “Ubiquiti” or the “Company”) develop high performance networking technology for service providers, enterprises, and consumers globally.

The Company operates on a fiscal year ending June 30. In these notes, Ubiquiti refers to the fiscal years ending June 30, 2024 and 2023, as fiscal 2024 and fiscal 2023, respectively.

Basis of Presentation— The Company’s consolidated financial statements and accompanying notes are prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) related to interim financial statements based on applicable Securities and Exchange Commission (“SEC”) rules and regulations. Accordingly, they do not include all the information and footnotes required by GAAP for complete financial statements. These consolidated financial statements reflect all adjustments, which are, in the opinion of the Company, of a normal and recurring nature and those necessary to state fairly the statements of financial position, results of operations and cash flows for the dates and periods presented. The June 30, 2023 balance sheet was derived from the audited consolidated financial statements as of that date. All significant intercompany transactions and balances have been eliminated.

These consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements for the fiscal year ended June 30, 2023, included in its Annual Report on Form 10-K, as filed with the SEC on August 25, 2023 (the “Annual Report”). The results of operations for the three and nine months ended March 31, 2024 are not necessarily indicative of the results to be expected for any future periods.
v3.24.1.1.u2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
9 Months Ended
Mar. 31, 2024
Accounting Policies [Abstract]  
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
The Company’s significant accounting policies are disclosed in its audited consolidated financial statements for the fiscal year ended June 30, 2023, included in the Annual Report on Form 10-K. There have been no changes to the Company’s significant accounting policies as discussed in the Annual Report.

Use of Accounting Estimates

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported and disclosed in the consolidated financial statements and the accompanying notes. Those estimates and assumptions include, but are not limited to, revenue recognition and deferred revenue; sales return reserves; inventory valuation and vendor deposits; accounting for income taxes, including the valuation allowance on deferred tax assets and reserves for uncertain tax positions. We evaluate our estimates and assumptions based on historical experience and other assumptions that are believed to be reasonable under the circumstances. Actual results could differ materially from those estimates.

Recent Accounting Pronouncements Not Yet Effective

Segment Reporting
In November 2023, the FASB issued ASU No. 2023-07, Segment Reporting (Topic 280) (“ASU 2023-07”), which enhances the segment disclosure requirements for public entities on an annual and interim basis. Under this proposal, public entities will be required to disclose significant segment expenses that are regularly provided to the chief operating decision maker (the “CODM”) and included within each reported measure of segment profit or loss. Additionally, current annual disclosures about a reportable segment’s profit or loss and assets will be required on an interim basis. Entities will also be required to disclose information about the CODM’s title and position at the Company along with an explanation of how the CODM uses the reported measures of segment profit or loss in their assessment of segment performance and deciding whether how to allocate resources. Finally, ASU 2023-07 requires all segment disclosures for public entities, even those with a single reportable segment. The amendments in ASU 2023-07 will become effective on a retrospective basis for annual disclosures in the Company's fiscal year beginning July 1, 2024, with interim period disclosures required effective with the Company's fiscal year beginning July 1, 2025. Early adoption of ASU 2023-07 is permitted. We do not expect this ASU to have a significant impact on our disclosures or results of operations, cash flows, and financial condition.

Income Taxes
In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740) ("ASU 2023-09"), which amends the existing guidance relating to the annual disclosures for accounting for income taxes. ASU 2023-09 requires a public business entity to disclose a tabular rate reconciliation using specified categories and providing additional information for reconciling items that exceed a quantitative threshold. In addition, ASU 2023-09 requires the disaggregation of federal, state and foreign income taxes paid (net of
funds received), with further disaggregation required for individual jurisdictions in which the income taxes paid exceed five percent of the Company's total income taxes paid. The provision for income taxes in the Company's statement of operations will also be required to be disaggregated by federal, state and foreign. The amendments in ASU 2023-09 will become effective for annual disclosures in the Company's fiscal year beginning July 1, 2025, with early adoption permitted. The FASB indicated ASU 2023-09 should be applied on a prospective basis, but retrospective application is permitted. We expect this ASU to only impact our disclosures with no impact to our results of operations, cash flows, and financial condition.
v3.24.1.1.u2
REVENUES
9 Months Ended
Mar. 31, 2024
Revenue from Contract with Customer [Abstract]  
REVENUES REVENUES
Revenue is primarily generated from the sale of hardware as well as the related implied post contract services ("PCS").

Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring goods or providing services. Revenue is recognized when obligations under the terms of a contract with our customers are satisfied; generally, this occurs with the transfer of control of our products and PCS to our customers. Transfer of control to the customer for products generally occurs at the point in time when products have been shipped to our customer as this represents the point in time when the customer has a present obligation to pay and physical possession including title and risk of loss have been transferred to the customer. Revenue for PCS is recognized ratably over time over the estimated period for which implied PCS services will be delivered.

Disaggregation of Revenue

See Note 13, "Segment Information, Revenues by Geography and Significant Customers" for disaggregation of revenue by product category and geography.

Contract Balances

The timing of revenue recognition, billing and cash collections results in billed accounts receivable, deferred revenue primarily attributable to PCS and customer deposits on the consolidated balance sheets. Accounts receivable are recognized in the period our right to the consideration is unconditional. Our contract liabilities consist of advance payments (Customer deposits) as well as billing in excess of revenue recognized primarily related to deferred revenue. We classify customer deposits as a current liability, and deferred revenue as a current or non-current liability based on the timing of when we expect to fulfill these remaining performance obligations. The current portion of deferred revenue is included in other current liabilities and the non-current portion is included in other long-term liabilities in our consolidated balance sheets.

As of March 31, 2024 and June 30, 2023, the Company’s customer deposits were $1.7 million and $1.2 million, respectively.

As of March 31, 2024, the Company’s deferred revenue, included in other current liabilities and other long-term liabilities, was $18.8 million and $11.1 million, respectively.

As of June 30, 2023, the Company’s deferred revenue, included in other current liabilities and other long-term liabilities, was $17.9 million and $7.8 million, respectively.

We expect the majority of our deferred revenue to convert to revenue in two years. For the three and nine months ended March 31, 2024 we recognized revenues amounting to $3.7 million and $14.7 million respectively from the deferred revenue balance as of June 30, 2023. For the three and nine months ended March 31, 2023, we recognized revenues amounting to $4.0 million and $17.6 million respectively from the deferred revenue balance as of June 30, 2022.
v3.24.1.1.u2
EARNINGS PER SHARE
9 Months Ended
Mar. 31, 2024
Earnings Per Share [Abstract]  
EARNINGS PER SHARE EARNINGS PER SHARE
The following table sets forth the computation of basic and diluted earnings per share for the periods indicated (in thousands, except per share data):
 Three Months Ended March 31,Nine Months Ended March 31,
 2024202320242023
Numerator:
Net income$76,290 $98,577 $246,156 $303,964 
Denominator:
Weighted-average shares used in computing basic earnings per share60,461 60,441 60,452 60,432 
Add—dilutive potential common shares:
Restricted stock units14 19 
Weighted-average shares used in computing diluted net income per share60,463 60,455 60,455 60,451 
Net income per share of common stock:
Basic$1.26 $1.63 $4.07 $5.03 
Diluted$1.26 $1.63 $4.07 $5.03 

The Company excludes potentially dilutive securities from its diluted net income per share calculation when their effect would be anti-dilutive to net income per share amounts.
v3.24.1.1.u2
BALANCE SHEET COMPONENTS
9 Months Ended
Mar. 31, 2024
Balance Sheet Related Disclosures [Abstract]  
BALANCE SHEET COMPONENTS BALANCE SHEET COMPONENTS
Inventories

Inventories consisted of the following (in thousands):
March 31, 2024June 30, 2023
Finished goods$450,230 $643,499 
Raw materials83,299 93,622 
Total$533,529 $737,121 

Property and Equipment, Net

Property and equipment, net consisted of the following (in thousands):
March 31, 2024June 30, 2023
Testing equipment$18,620 $18,265 
Tooling equipment24,450 22,687 
Leasehold improvements26,177 24,968 
Computer and other equipment10,475 10,860 
Software9,372 9,421 
Furniture and fixtures1,863 1,716 
Corporate aircraft65,807 65,807 
Property and equipment, gross156,764 153,724 
Less: Accumulated depreciation and amortization(74,559)(66,879)
Property and equipment, net$82,205 $86,845 
Other Long-term Assets

Other long-term assets consisted of the following (in thousands):
March 31, 2024June 30, 2023
Hong Kong Tax deposit (1)
$60,189 $60,106 
Intangible assets, net (2)
4,554 5,695 
Other long-term assets, net4,607 5,523 
Total$69,350 $71,324 
(1) The Company expects the deposits made with the Hong Kong Inland Revenue Department (“IRD”) to be refunded upon completion of the audit. See Note 12, "Income Taxes" to the consolidated financial statements for additional details regarding this ongoing tax audit.
(2) Accumulated amortization was $7.1 million and $5.9 million as of March 31, 2024, and June 30, 2023, respectively.

Other Current Liabilities

Other current liabilities consisted of the following (in thousands):
March 31, 2024June 30, 2023
Deferred revenue — short-term$18,814 17,911 
Accrued expenses18,708 23,426 
Lease liability— current14,004 14,333 
Warranty accrual10,343 8,745 
Accrued compensation and benefits6,472 7,330 
Customer deposits1,656 1,211 
Reserve for sales returns4,480 4,999 
Inventory received not billed53,298 56,862 
Other payables14,743 7,028 
Total$142,518 $141,845 

Other Long-Term Liabilities

Other long-term liabilities consisted of the following (in thousands):
March 31, 2024June 30, 2023
Deferred revenue — long-term$11,131 $7,774 
v3.24.1.1.u2
ACCRUED WARRANTY
9 Months Ended
Mar. 31, 2024
Product Warranties Disclosures [Abstract]  
ACCRUED WARRANTY ACCRUED WARRANTY
The Company offers warranties on certain products, generally a period of one to two years and records a liability for the estimated future costs associated with potential warranty claims. The warranty costs are reflected in the Company’s consolidated statements of operations and comprehensive income within cost of revenues. The warranties are typically in effect for one year for distributors from the date of shipment and two years for direct sales from the date of delivery. The Company assesses the adequacy of its accrued warranty liabilities and adjusts the amounts as necessary based on historical experience factors and changes in future estimates. Historical factors include product failure rates, material usage and service delivery costs incurred in correcting product failures. In certain circumstances, the Company may have recourse from its contract manufacturers for replacement cost of defective products, which it also factors into its warranty liability assessment.
Warranty obligations, included in other current liabilities, were as follows (in thousands):
 Nine Months Ended March 31,
 20242023
Beginning balance$8,745 $6,394 
Accruals for warranties issued during the period9,463 8,344 
Changes in liability for pre-existing warranties during the period887 206 
Settlements made during the period(8,752)(7,001)
Ending balance$10,343 $7,943 
v3.24.1.1.u2
DEBT
9 Months Ended
Mar. 31, 2024
Debt Disclosure [Abstract]  
DEBT DEBT
On March 30, 2021, the Company, as borrower and certain domestic subsidiaries, as guarantors (the "Domestic Guarantors"), entered into an amended and restated credit agreement (the “Third Amended and Restated Credit Agreement”) with Wells Fargo Bank, National Association (“Wells Fargo”), the other financial institutions named as lenders therein, and Wells Fargo as administrative agent and collateral agent for the lenders, that extended the $700 million senior secured revolving credit facility (the “Revolving Facility,” together with the Term Loan Facilities, as defined below, the "Facilities") and provided a $500 million senior secured term loan facility (the “Initial Term Loan Facility”), and extended the maturity of the Facilities to March 30, 2026. In addition, the Facilities include an option to request increases in the amounts of such credit facilities by up to an additional $500 million in the aggregate. The loans under the Initial Term Loan Facility are payable in quarterly installments of $6.25 million per quarter, commencing with the quarter ending June 30, 2021.

On April 3, 2023, the Company as borrower and the Domestic Guarantors entered into a first amendment (the “First Amendment”) to the Third Amended and Restated Credit Agreement (as amended, the “Amended Credit Agreement”) with the financial institutions named as lenders therein and Wells Fargo. The First Amendment added a new term loan facility in an aggregate principal amount of $250 million (the “First Amendment Term Loan Facility,” together with the Initial Term Loan Facility, the "Term Loan Facilities") which is payable in quarterly installments equal to $3.125 million, commencing with the quarter ended June 30, 2023, and has a maturity date of March 30, 2026. The obligations of the Company and certain domestic subsidiaries under the Amended Credit Agreement are required to be guaranteed by the Domestic Guarantors and are collateralized by substantially all assets (excluding intellectual property) of the Company and the Domestic Guarantors.

The Company's unamortized balance of debt issuance costs are $2.0 million as of March 31, 2024, which are amortized as interest expense over the life of the Facilities.

The Company's debt consisted of the following (in thousands):
March 31, 2024June 30, 2023
Initial Term Loan Facility - short term$25,000 $25,000 
First Amendment Term Loan Facility - short-term12,500 12,500 
Debt issuance costs, net(992)(992)
Total Debt - short term36,508 36,508 
Initial Term Loan Facility - long term400,000 418,750 
First Amendment Term Loan Facility - long-term225,000 234,375 
Revolving Facility - long term215,000 390,000 
Debt issuance costs, net(995)(1,744)
Total Debt - long term$839,005 $1,041,381 

The Revolving Facility includes a sub-limit of $25.0 million for letters of credit and a sub-limit of $25.0 million for swingline loans. The Facilities are available for working capital and general corporate purposes that comply with the terms of the Amended Credit Agreement, including to finance the repurchase of the Company’s common stock or to make dividends to the holders of the Company's common stock. Under the Amended Credit Agreement, revolving loans and swingline loans may be borrowed, repaid and reborrowed until March 30, 2026, at which time all amounts borrowed must be repaid. Loans under the Facilities may be prepaid at any time without penalty.

The revolving loans and term loans under the Initial Term Loan Facility bear interest, at the Company’s option, at either (i) a floating rate per annum equal to the Base Rate (as defined below) plus a margin of between 0.50% and 1.25%, depending on the Company’s consolidated total leverage ratio as of the most recently ended fiscal quarter or (ii) a floating per annum rate equal to the Adjusted
Term SOFR (as defined below) for a specified period, plus a margin of between 1.50% and 2.25%, depending on the Company’s consolidated total leverage ratio as of the most recently ended fiscal quarter. Swingline loans bear interest at a floating rate per annum equal to the Base Rate plus a margin of between 0.50% and 1.25%, depending on the Company’s consolidated total leverage ratio as of the most recently ended fiscal quarter. The loans under the First Amendment Term Loan Facility bear interest, at the Company's option, at either (i) a floating rate per annum equal to Base Rate plus a margin of between 1.00% and 1.75%, depending on the Company’s consolidated total leverage ratio as of the most recently ended fiscal quarter or (ii) a floating per annum rate equal to the applicable Adjusted Term SOFR rate for a specified period, plus a margin between 2.00% and 2.75%, depending on the Company's consolidated total leverage ratio as of the most recently ended fiscal quarter. Base Rate is defined in the Amended Credit Agreement as the highest of (a) the Prime Rate (as defined in the Amended Credit Agreement), (b) the Federal Funds Rate (as defined in the Amended Credit Agreement) plus 0.50% and (c) Adjusted Term SOFR for a one-month tenor in effect on such day plus 1.00%; each change in the Base Rate shall take effect simultaneously with the corresponding change or changes in the Prime Rate, the Federal Funds Rate or Adjusted Term SOFR, as applicable (provided that clause (c) shall not be applicable during any period in which Adjusted Term SOFR is unavailable or unascertainable). The Base Rate shall not be less than 1.00%. Adjusted Term SOFR is Term SOFR (as defined in the Amended Credit Agreement) plus 0.10% per annum; provided that Adjusted Term SOFR shall in no event be less than 0.00%.

A default interest rate shall apply on all obligations during certain events of default under the Amended Credit Agreement at a rate per annum equal to 2.00% above the applicable interest rate. The Company will pay to each lender a facility fee on a quarterly basis based on the unused amount of each lender’s commitment to make revolving loans, of between 0.20% and 0.35%, depending on the Company’s consolidated total leverage ratio as of the most recently ended fiscal quarter. The Company will also pay to the applicable lenders on a quarterly basis certain fees based on the daily amount available to be drawn under each outstanding letter of credit, including aggregate letter of credit commissions of between 1.50% and 2.25%, depending on the Company’s consolidated total leverage ratio as of the most recently ended fiscal quarter, and issuance fees of 0.125% per annum. The Company is also obligated to pay Wells Fargo, as agent, fees customary for a credit facility of this size and type.

The Amended Credit Agreement requires the Company to maintain during the term of the Facilities a maximum consolidated total leverage ratio of 3.50 to 1.00 and a minimum consolidated interest coverage ratio of 3.50 to 1.00. In addition, the Amended Credit Agreement contains customary affirmative and negative covenants, including covenants that limit or restrict the ability of the Company and its subsidiaries to, among other things, grant liens or enter into agreements restricting their ability to grant liens on property, enter into mergers, dispose of assets, change their accounting or reporting policies, change their business and incur indebtedness, in each case subject to customary exceptions for a credit facility of this size and type. The Amended Credit Agreement includes customary events of default that include, among other things, non-payment of principal, interest or fees, inaccuracy of representations and warranties, violation of covenants, cross default to certain other indebtedness, bankruptcy and insolvency events, material judgments, change of control and certain ERISA events. The occurrence of an event of default could result in the acceleration of the obligations under the Amended Credit Agreement.

The Facilities

As of March 31, 2024, $425.0 million was outstanding on the Initial Term Loan Facility, $237.5 million was outstanding on the First Amendment Term Loan Facility, and $215.0 million was outstanding on the Revolving Facility, leaving $485.0 million available on the Revolving Facility.

Term Loan Facilities

During the nine months ended March 31, 2024, the Company made aggregate payments of $67.7 million under the Term Loan Facilities, of which $28.1 million was repayment of principal and $39.6 million was payment of interest.

Revolving Facility

Under the Amended Credit Agreement, during the nine months ended March 31, 2024, the Company made aggregate payments of $195.0 million under the Revolving Facility, of which $175 million was repayment of principal and $20.0 million was payment of interest.

The following table summarizes the Company’s estimated debt and interest payment obligations as of March 31, 2024, for the remainder of fiscal 2024 and future fiscal years (in thousands):
2024 (remainder)
2025202620272028ThereafterTotal
Debt payment obligations$9,375 $37,500 $830,625 $— $— $— $877,500 
Interest and other payments on debt payment obligations (1)
16,227 63,384 45,624 — — — 125,235 
Total$25,602 $100,884 $876,249 $— $— $— $1,002,735 
(1) Interest payments are calculated based on the applicable rates and payment dates as of March 31, 2024. Although our interest rates on our debt obligations may vary, we have assumed the most recent available interest rates for all periods presented.
v3.24.1.1.u2
LEASES
9 Months Ended
Mar. 31, 2024
Leases [Abstract]  
LEASES LEASES
The Company has entered into agreements under which we lease various real estate spaces in North America, Europe and Asia Pacific, under non-cancellable leases that expire on various dates through fiscal 2036. Some of our leases include options to extend the term of such leases for a period from 12 months to 60 months, and/or have options to early terminate the lease. As of March 31, 2024, we included such options in determining the lease terms for certain of our leases because we were reasonably certain that we would exercise the extension options. Most of our leases require us to pay certain operating expenses in addition to base rent, such as taxes, insurance and maintenance costs.

The following table summarizes our lease costs for the three and nine months ended March 31, 2024 and 2023 (in thousands):
Financial Statement ClassificationThree Months Ended March 31,Nine Months Ended March 31,
2024202320242023
Operating lease costs:
Fixed lease costsOperating expenses$2,892 $2,761 $8,684 $8,287 
Fixed lease costsCost of revenues1,126 1,010 2,951 2,975 
Variable lease costsOperating expenses229 234 555 388 
Variable lease costsCost of revenues44 149 511 305 
Total lease costs$4,291 $4,154 $12,701 $11,955 

The operating lease costs in the table above include costs for long-term and short-term leases. Total short-term costs for the three and nine months ended March 31, 2024 and 2023, were immaterial. Variable lease costs primarily include maintenance, utilities and operating expenses that are incremental to the fixed base rent payments and are excluded from the calculation of operating lease liabilities and ROU assets. For the three months ended March 31, 2024 and 2023, cash paid for amounts associated with the Company's operating lease liabilities were approximately $4.3 million and $3.8 million, respectively. For the nine months ended March 31, 2024 and 2023, cash paid for amounts associated with the Company's operating lease liabilities were approximately $12.9 million and $11.4 million, respectively. Cash paid for amounts associated with the Company’s operating lease liabilities were classified as operating activities in the consolidated statement of cash flows.

The following table shows the Company’s undiscounted future fixed payment obligations under the Company’s recognized operating leases and a reconciliation to the operating lease liabilities as of March 31, 2024:
Remainder of Fiscal 2024
$4,012 
Fiscal 2025
14,605 
Fiscal 2026
10,299 
Fiscal 2027
6,213 
Fiscal 2028
4,825 
Thereafter15,950 
Total future fixed operating lease payments$55,904 
Less: Imputed interest$4,406 
Total operating lease liabilities$51,498 
Weighted-average remaining lease term - operating leases6 years
Weighted-average discount rate - operating leases3.2 %
v3.24.1.1.u2
COMMITMENTS AND CONTINGENCIES
9 Months Ended
Mar. 31, 2024
Commitments and Contingencies Disclosure [Abstract]  
COMMITMENTS AND CONTINGENCIES COMMITMENTS AND CONTINGENCIES
Purchase Obligations

We subcontract with third parties to manufacture our products and supply key components. As of March 31, 2024, we had $949.5 million of purchase commitments with these third parties. If we cancel all or part of the orders, we may still be liable to the contract manufacturers for the cost of the components purchased by the subcontractors to manufacture our products. There have been no significant liabilities for current or anticipated cancellations recorded as of March 31, 2024. Our consolidated financial position and results of operations could be negatively impacted if we were required to compensate these third parties. In addition, we may be subject to additional purchase obligations to our contract manufacturers for supply agreements and components ordered by them based on manufacturing forecasts we provide them each month.

Transition Tax

We have an obligation of $50.6 million as of March 31, 2024, related to the mandatory transition tax on accumulated foreign earnings from the 2017 Tax Cuts and Jobs Act. We expect to make payments of $22.5 million and $28.1 million in the first quarter of fiscal 2025 and 2026, respectively, in relation to this obligation. This obligation is included within Income tax payable and Long-term taxes payable on our consolidated balance sheets.

Other Obligations

As of March 31, 2024, the Company has other obligations of $5.8 million which consisted primarily of commitments related to research and development projects.

Indemnification Obligations

The Company enters into standard indemnification agreements with many of its business partners in the ordinary course of business. These agreements include provisions for indemnifying the business partner against any claim brought by a third-party to the extent any such claim alleges that a Company product infringes a patent, copyright or trademark, or violates any other proprietary rights of that third-party. The maximum potential amount of future payments the Company could be required to make under these indemnification agreements is not estimable and the Company has not incurred any material costs to defend lawsuits or settle claims related to these indemnification agreements to date.

Legal Matters

The Company may be involved, from time to time, in a variety of claims, lawsuits, investigations, and proceedings relating to contractual disputes, intellectual property rights, employment matters, regulatory compliance matters and other litigation matters relating to various claims that arise in the normal course of business. The Company determines whether an estimated loss from a contingency should be accrued by assessing whether a loss is deemed probable and can be reasonably estimated. The Company assesses its potential liability by analyzing specific litigation and regulatory matters using available information. The Company develops its views on estimated losses in consultation with inside and outside counsel, which involves a subjective analysis of potential results and outcomes, assuming various combinations of appropriate litigation and settlement strategies. Taking all of the above factors into account, the Company records an amount where it is probable that the Company will incur a loss and where that loss can be reasonably estimated. However, the Company’s estimates may be incorrect and the Company could ultimately incur more or less than the amounts initially recorded. The Company may also incur significant legal fees, which are expensed as incurred, in defending against these claims. The Company is not currently aware of any pending or threatened litigation that would have a material adverse effect on the Company’s financial statements.

Vivato/XR

On April 19, 2017, XR Communications, LLC, d/b/a Vivato Technologies (“Vivato”), filed a complaint against the Company in the United States District Court for the Central District of California, alleging that at least one of the Company’s products infringes United States Patent Numbers 7,062,296 (the “'296 Patent”), 7,729,728 (the “'728 Patent”), and 6,611,231 (the “'231 Patent” and, collectively, the “Patents-in-Suit”) (the “Original Action”). On April 11, 2018, the Court stayed the Original Action pending completion of certain inter partes review (“IPR”) proceedings before the Patent Trial and Appeal Board (“PTO”). The PTO invalidated asserted claims of two of the three Patents-in-Suit.

On June 16, 2021, Vivato filed a new suit against the Company in the Central District of California, alleging that various Company products infringe some of the non-invalidated claims of the ’728 Patent and U.S. Patent No. 10,594,376 (the “New Action”). On
November 24, 2021, the Company and the remaining defendants in the Original Action filed a motion for judgment on the pleadings regarding the '231 Patent. On January 4, 2022, the Court granted defendants’ motion and dismissed Vivato’s claims based on the '231 Patent. The Federal Circuit Court of Appeals affirmed the invalidity of the '231 Patent on May 18, 2023. All claims asserted against the Company in the Original Action have been dismissed.

On July 28, 2022, Vivato voluntarily dismissed, with prejudice, its remaining claims related to the '728 patent, as well as claims 22-31 of the '376 Patent. On October 20, 2022, an IPR was instituted with respect to the asserted claims of the '376 Patent. On October 26, 2022, the court stayed the case pending completion of the IPR. On October 3, 2023, the IPR with respect to the '376 Patent was terminated after the petitioners entered into a settlement agreement with Vivato. On November 10, 2023, the Company filed a new IPR petition with respect to the '376 Patent and a motion to reopen the prior IPR proceeding, which remains pending. On December 4, 2023, the court lifted the stay. Trial is currently scheduled for June 25, 2024.

The Company plans to vigorously defend itself against these claims; however, there can be no assurance that the Company will prevail in the lawsuit. The Company cannot currently estimate the possible loss or range of losses, if any, that it may experience in connection with this litigation.

Network-1 Technologies, Inc.

On October 5, 2022, Network-1 Technologies, Inc. ("Network-1") filed a patent infringement lawsuit against the Company in the District of Delaware, alleging that various Company products infringe United States Patent Number 6,218,930, which relates to 802.3af and 802.3at Power over Ethernet standards. Network-1 seeks compensatory and enhanced damages, attorneys' fees and costs, and pre- and post-judgment interest. The Company plans to vigorously defend itself against these claims; however, there can be no assurance that the Company will prevail in the lawsuit. The Company cannot currently estimate the possible loss or range of losses, if any, that it may experience in connection with this litigation.

Intellectual Ventures I LLC v. Ubiquiti Inc.

On August 8, 2023, Intellectual Ventures I LLC ("IV") filed a patent infringement lawsuit against the Company in the District of Delaware, alleging that various Company products infringe United States Patent Number 8,594,122, which relates to 802.11ac Beamforming standards. IV seeks compensatory and enhanced damages, attorneys' fees and costs, and pre- and post-judgment interest. The Company plans to vigorously defend itself against these claims; however, there can be no assurance that the Company will prevail in the lawsuit. The Company cannot currently estimate the possible loss or range of losses, if any, that it may experience in connection with this litigation.
v3.24.1.1.u2
COMMON STOCK AND TREASURY STOCK
9 Months Ended
Mar. 31, 2024
Equity [Abstract]  
COMMON STOCK AND TREASURY STOCK COMMON STOCK AND TREASURY STOCK
Common Stock Repurchases
On May 3, 2022, the Board of Directors of the Company approved a $200 million stock repurchase program (the “2022 May Program”). Under the 2022 May Program, the Company was authorized to repurchase up to $200 million of common stock. The 2022 May Program expired on September 30, 2023, and the Company did not make any repurchases under the 2022 May Program.
v3.24.1.1.u2
SHARE-BASED COMPENSATION
9 Months Ended
Mar. 31, 2024
Share-Based Payment Arrangement [Abstract]  
SHARE-BASED COMPENSATION SHARE-BASED COMPENSATION
Share-Based Compensation Plans

The Company’s 2020 and 2010 Equity Incentive Plans are described in the Company’s Annual Report.

As of March 31, 2024, the Company had 4,880,028 authorized shares available for future issuance under all of its stock incentive plans.
Share-Based Compensation

The following table shows total share-based compensation expense included in the consolidated statements of operations and comprehensive income for the three and nine months ended March 31, 2024 and 2023 (in thousands):

 Three Months Ended March 31,Nine Months Ended March 31,
 2024202320242023
Cost of revenues$44 $24 $113 $47 
Research and development1,272 942 3,567 2,524 
Sales, general and administrative348 280 991 823 
1,664 1,246 $4,671 $3,394 

Stock Options

There were no options exercised under the Company’s stock incentive plans during the three months ended March 31, 2024 and 2023.

During the nine months ended March 31, 2024 and 2023, the aggregate intrinsic value of options exercised under the Company’s stock incentive plans was $0.0 million and $0.6 million, respectively, as determined as of the date of option exercise.

As of March 31, 2024, the Company had no unrecognized compensation costs related to stock options, and the Company did not grant any employee stock options during the three and nine months ended March 31, 2024, and 2023.

Restricted Stock Units (“RSUs”)

The following table summarizes the activity of the RSUs made by the Company:

Number of SharesWeighted Average Grant Date Fair Value Per Share
Non-vested RSUs, June 30, 2023
62,948 $256.78 
RSUs granted60,309 $149.97 
RSUs vested(21,972)$238.65 
RSUs canceled(1,408)$293.51 
Non-vested RSUs, March 31, 2024
99,877 $195.76 

The intrinsic value of RSUs vested in the three months ended March 31, 2024 and 2023 was $1.9 million and $3.1 million, respectively.

The intrinsic value of RSUs vested in the nine months ended March 31, 2024 and 2023 was $3.3 million and $5.8 million, respectively.

The total intrinsic value of all outstanding RSUs was $11.6 million as of March 31, 2024.

As of March 31, 2024, there were unrecognized compensation costs related to RSUs of $14.3 million which the Company expects to recognize over a weighted average period of 3.5 years.
v3.24.1.1.u2
INCOME TAXES
9 Months Ended
Mar. 31, 2024
Income Tax Disclosure [Abstract]  
INCOME TAXES INCOME TAXES
The Company recorded tax provisions of $16.1 million and $56.1 million for the three and nine months ended March 31, 2024 as compared to $18.5 million and $58.3 million for the three and nine months ended March 31, 2023. Our effective tax rate increased to 17.4% for the three months ended March 31, 2024 as compared to 15.8% for the three months ended March 31, 2023. Our effective tax rate increased from 16.1% for the nine months ended March 31, 2023 to 18.6% for the nine months ended March 31, 2024.

The change in effective tax rates for the three and nine months ended March 31, 2024, as compared to the same periods in the prior year, was primarily driven by a combination of changes in the mix of the income earned in various tax jurisdictions, a one-time release
of a reserve for unrecognized tax benefit due to statute of limitation during the nine months ended March 31, 2023, as well as a one-time benefit for state income taxes recognized during the three and nine months ended March 31, 2024.

The Company’s estimated fiscal year 2024 effective tax rate, before discrete items, differs from the U.S. statutory rate primarily due to profits earned in jurisdictions where the tax rate is lower than the U.S. tax rate, partially offset by additional U.S. tax related to our non-U.S. operations under the Global Intangible Low-Taxes Income ("GILTI") rules.

As of March 31, 2024, the Company had approximately $35.9 million of unrecognized tax benefits, substantially all of which would, if recognized, affect its tax expense. Accrued interest and penalties are included within the related tax liability line in the consolidated balance sheets. As of March 31, 2024, the Company had $5.0 million accrued interest related to uncertain tax matters.

The Company and one or more of its subsidiaries, file income tax returns in the United States federal jurisdiction, and various state, local, and foreign jurisdictions and is currently undergoing income tax examinations by the U.S. Internal Revenue Service (IRS) and the Hong Kong Inland Revenue Department (“IRD”). All material consolidated federal, state and local income tax matters have been concluded for years through 2014. The majority of the Company's foreign jurisdictions have been concluded through 2014, with the exception of Hong Kong which has been reviewed through 2009 and is currently under audit for the 2010-2018 statutory tax years.

In July 2018, the Company received a draft Notice of Proposed Adjustment (“Draft NOPA”) from the IRS proposing an adjustment to income for the fiscal 2015 and fiscal 2016 tax years based on its interpretation of certain obligations of the non-US entities under the credit facility. This Draft NOPA was superseded by an Acknowledgement of Facts (“AOF”) issued to the Company by the IRS on January 17, 2020. The IRS in its AOF continued to propose an adjustment to the Company’s income for its fiscal 2015 and fiscal 2016 tax years based on the IRS’ interpretation of certain obligations of the Company’s foreign subsidiaries under the Company’s credit facilities. On May 12, 2020, the IRS issued a final Notice of Proposed Adjustment to the Company with respect to the 2015/2016 tax years. The Company formally protested the adjustment and the case was moved from the Examination Division to the IRS Appeals Division where a formal review of the facts and the applicable law took place on May 9, 2022. The Appeals Officer issued a Notice of Deficiency on August 3, 2022, which upheld the position of the Examination Division. The Company filed a petition with the United States Tax Court seeking to have the Notice of Deficiency reversed. On November 8, 2023, the Company filed a Motion for Summary Judgment. The IRS responded to our Motion on December 26, 2023 and filed a Cross-Motion for Summary Judgment. On January 22, 2024, the judge assigned to this case rejected both Motions for Summary Judgment. As such, the Company is awaiting a trial date to be set which it currently expects to receive by the end of December 2024. The Company strongly believes the position of the IRS with regard to this matter is without merit. However, there can be no assurance that this matter will be resolved in the Company’s favor. Regardless of whether the matter is resolved in the Company’s favor, the final resolution of this matter could be expensive and time-consuming to defend and/or settle. We estimate the incremental tax liability associated with the income adjustment proposed in the AOF would be approximately $50.0 million, excluding potential interest and penalties, after adjusting for the impact of an adjustment on the amount of transition tax payable in future years by the Company. As the Company believes that the tax originally paid in fiscal 2015 and fiscal 2016 is correct, it has not provided a reserve for this tax uncertainty. However, an adverse outcome may have a material and adverse effect on the Company’s results of operations and financial condition.

Between fiscal years 2018 and 2023, the Company made payments totaling a combined amount of $60.4 million as deposits with the Hong Kong IRD in connection with extending the statute of limitation for income tax examinations currently under audit for 2010-2017 statutory tax years. On March 27, 2024, the Company received notification that the Hong Kong IRD is seeking an additional $0.8 million deposit covering the 2018 statutory tax year. The Company filed a formal protest in response to this notice and the Assessor's office agreed to a reduced deposit of $0.1 million covering the 2018 statutory tax year. The refundable deposits are included within other long-term assets on our Consolidated Balance Sheets. The IRD is examining the Company’s claims that its revenue is generated through activities performed wholly outside of the Hong Kong tax jurisdiction and are therefore exempt from Hong Kong tax. The Company is fully cooperating with the examination including submitting documentation in support of its position. The Company continues to believe that its tax positions filed with IRD are more likely than not to be sustained based on their technical merits and therefore no reserve has been provided for this tax uncertainty and we expect the $60.2 million (net of foreign currency impact) of deposits made with IRD to be refunded upon completion of the audit. However, there can be no assurance that this matter will be resolved in the Company’s favor and therefore it's possible that an adverse outcome of the matter could have a material effect on the Company’s results of operations and financial condition.
v3.24.1.1.u2
SEGMENT INFORMATION, REVENUES BY GEOGRAPHY AND SIGNIFICANT CUSTOMERS
9 Months Ended
Mar. 31, 2024
Segment Reporting [Abstract]  
SEGMENT INFORMATION, REVENUES BY GEOGRAPHY AND SIGNIFICANT CUSTOMERS SEGMENT INFORMATION, REVENUES BY GEOGRAPHY AND SIGNIFICANT CUSTOMERS
Management has determined that the Company operates as one reportable and operating segment as the Company’s Chief Executive Officer, who is the Company’s chief operating decision maker, does not make decisions about resources to be allocated or assess performance on a segment basis. Furthermore, the Company does not organize or report its costs on a segment basis. The Company presents its revenues by product type in two primary categories: Service Provider Technology and Enterprise Technology.

Revenues by product type are as follows (in thousands, except percentages):
 Three Months Ended March 31,Nine Months Ended March 31,
 2024202320242023
Enterprise technology$414,345 84 %$373,573 82 %$1,185,932 83 %$1,217,279 84 %
Service provider technology78,652 16 %84,200 18 %235,097 17 %232,148 16 %
Total revenues$492,997 100 %$457,773 100 %$1,421,029 100 %$1,449,427 100 %

Revenues by geography based on customer’s ship-to destinations were as follows (in thousands, except percentages):
 Three Months Ended March 31,Nine Months Ended March 31,
 2024202320242023
North America (1)
$242,511 49 %$230,741 50 %$693,154 49 %$683,907 47 %
Europe, the Middle East and Africa (“EMEA”)200,666 41 %173,262 38 %546,010 38 %568,502 39 %
Asia Pacific26,459 %26,880 %95,815 %116,158 %
South America23,361 %26,890 %86,050 %80,860 %
Total revenues$492,997 100 %$457,773 100 %$1,421,029 100 %$1,449,427 100 %
 (1) Revenue for the United States was $226.2 million and $214.3 million for the three months ended March 31, 2024 and 2023, respectively. Revenue for the United States was $645.8 million and $634.0 million for the nine months ended March 31, 2024 and 2023, respectively.

For the periods presented, there were no customers with an accounts receivable balance of 10% or greater of total accounts receivable or customers with net revenues of 10% or greater of total revenues.
v3.24.1.1.u2
SUBSEQUENT EVENTS
9 Months Ended
Mar. 31, 2024
Subsequent Events [Abstract]  
SUBSEQUENT EVENTS SUBSEQUENT EVENTS
Dividends

On May 7, 2024, the Company's Board of Directors approved a quarterly cash dividend of $0.60 per share payable on May 28, 2024 to shareholders of record at the close of business on May 20, 2024. Any future dividends will be subject to the approval of the Company’s Board of Directors.
v3.24.1.1.u2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
9 Months Ended
Mar. 31, 2024
Accounting Policies [Abstract]  
Basis of Presentation
Basis of Presentation— The Company’s consolidated financial statements and accompanying notes are prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) related to interim financial statements based on applicable Securities and Exchange Commission (“SEC”) rules and regulations. Accordingly, they do not include all the information and footnotes required by GAAP for complete financial statements. These consolidated financial statements reflect all adjustments, which are, in the opinion of the Company, of a normal and recurring nature and those necessary to state fairly the statements of financial position, results of operations and cash flows for the dates and periods presented. The June 30, 2023 balance sheet was derived from the audited consolidated financial statements as of that date. All significant intercompany transactions and balances have been eliminated.

These consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements for the fiscal year ended June 30, 2023, included in its Annual Report on Form 10-K, as filed with the SEC on August 25, 2023 (the “Annual Report”). The results of operations for the three and nine months ended March 31, 2024 are not necessarily indicative of the results to be expected for any future periods.
Use of Accounting Estimates
Use of Accounting Estimates
The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported and disclosed in the consolidated financial statements and the accompanying notes. Those estimates and assumptions include, but are not limited to, revenue recognition and deferred revenue; sales return reserves; inventory valuation and vendor deposits; accounting for income taxes, including the valuation allowance on deferred tax assets and reserves for uncertain tax positions. We evaluate our estimates and assumptions based on historical experience and other assumptions that are believed to be reasonable under the circumstances. Actual results could differ materially from those estimates.
Recently Adopted Accounting Pronouncements
Recent Accounting Pronouncements Not Yet Effective

Segment Reporting
In November 2023, the FASB issued ASU No. 2023-07, Segment Reporting (Topic 280) (“ASU 2023-07”), which enhances the segment disclosure requirements for public entities on an annual and interim basis. Under this proposal, public entities will be required to disclose significant segment expenses that are regularly provided to the chief operating decision maker (the “CODM”) and included within each reported measure of segment profit or loss. Additionally, current annual disclosures about a reportable segment’s profit or loss and assets will be required on an interim basis. Entities will also be required to disclose information about the CODM’s title and position at the Company along with an explanation of how the CODM uses the reported measures of segment profit or loss in their assessment of segment performance and deciding whether how to allocate resources. Finally, ASU 2023-07 requires all segment disclosures for public entities, even those with a single reportable segment. The amendments in ASU 2023-07 will become effective on a retrospective basis for annual disclosures in the Company's fiscal year beginning July 1, 2024, with interim period disclosures required effective with the Company's fiscal year beginning July 1, 2025. Early adoption of ASU 2023-07 is permitted. We do not expect this ASU to have a significant impact on our disclosures or results of operations, cash flows, and financial condition.

Income Taxes
In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740) ("ASU 2023-09"), which amends the existing guidance relating to the annual disclosures for accounting for income taxes. ASU 2023-09 requires a public business entity to disclose a tabular rate reconciliation using specified categories and providing additional information for reconciling items that exceed a quantitative threshold. In addition, ASU 2023-09 requires the disaggregation of federal, state and foreign income taxes paid (net of
funds received), with further disaggregation required for individual jurisdictions in which the income taxes paid exceed five percent of the Company's total income taxes paid. The provision for income taxes in the Company's statement of operations will also be required to be disaggregated by federal, state and foreign. The amendments in ASU 2023-09 will become effective for annual disclosures in the Company's fiscal year beginning July 1, 2025, with early adoption permitted. The FASB indicated ASU 2023-09 should be applied on a prospective basis, but retrospective application is permitted. We expect this ASU to only impact our disclosures with no impact to our results of operations, cash flows, and financial condition.
Revenues
Disaggregation of Revenue

See Note 13, "Segment Information, Revenues by Geography and Significant Customers" for disaggregation of revenue by product category and geography.

Contract Balances

The timing of revenue recognition, billing and cash collections results in billed accounts receivable, deferred revenue primarily attributable to PCS and customer deposits on the consolidated balance sheets. Accounts receivable are recognized in the period our right to the consideration is unconditional. Our contract liabilities consist of advance payments (Customer deposits) as well as billing in excess of revenue recognized primarily related to deferred revenue. We classify customer deposits as a current liability, and deferred revenue as a current or non-current liability based on the timing of when we expect to fulfill these remaining performance obligations. The current portion of deferred revenue is included in other current liabilities and the non-current portion is included in other long-term liabilities in our consolidated balance sheets.
Accrued Warranty
The Company offers warranties on certain products, generally a period of one to two years and records a liability for the estimated future costs associated with potential warranty claims. The warranty costs are reflected in the Company’s consolidated statements of operations and comprehensive income within cost of revenues. The warranties are typically in effect for one year for distributors from the date of shipment and two years for direct sales from the date of delivery. The Company assesses the adequacy of its accrued warranty liabilities and adjusts the amounts as necessary based on historical experience factors and changes in future estimates. Historical factors include product failure rates, material usage and service delivery costs incurred in correcting product failures. In certain circumstances, the Company may have recourse from its contract manufacturers for replacement cost of defective products, which it also factors into its warranty liability assessment.
v3.24.1.1.u2
EARNINGS PER SHARE (Tables)
9 Months Ended
Mar. 31, 2024
Earnings Per Share [Abstract]  
Schedule of Computation of Basic and Diluted Earnings Per Share
The following table sets forth the computation of basic and diluted earnings per share for the periods indicated (in thousands, except per share data):
 Three Months Ended March 31,Nine Months Ended March 31,
 2024202320242023
Numerator:
Net income$76,290 $98,577 $246,156 $303,964 
Denominator:
Weighted-average shares used in computing basic earnings per share60,461 60,441 60,452 60,432 
Add—dilutive potential common shares:
Restricted stock units14 19 
Weighted-average shares used in computing diluted net income per share60,463 60,455 60,455 60,451 
Net income per share of common stock:
Basic$1.26 $1.63 $4.07 $5.03 
Diluted$1.26 $1.63 $4.07 $5.03 
v3.24.1.1.u2
BALANCE SHEET COMPONENTS (Tables)
9 Months Ended
Mar. 31, 2024
Balance Sheet Related Disclosures [Abstract]  
Schedule of Inventories
Inventories consisted of the following (in thousands):
March 31, 2024June 30, 2023
Finished goods$450,230 $643,499 
Raw materials83,299 93,622 
Total$533,529 $737,121 
Schedule of Property and Equipment, Net
Property and equipment, net consisted of the following (in thousands):
March 31, 2024June 30, 2023
Testing equipment$18,620 $18,265 
Tooling equipment24,450 22,687 
Leasehold improvements26,177 24,968 
Computer and other equipment10,475 10,860 
Software9,372 9,421 
Furniture and fixtures1,863 1,716 
Corporate aircraft65,807 65,807 
Property and equipment, gross156,764 153,724 
Less: Accumulated depreciation and amortization(74,559)(66,879)
Property and equipment, net$82,205 $86,845 
Schedule of Other Long-Term Assets
Other long-term assets consisted of the following (in thousands):
March 31, 2024June 30, 2023
Hong Kong Tax deposit (1)
$60,189 $60,106 
Intangible assets, net (2)
4,554 5,695 
Other long-term assets, net4,607 5,523 
Total$69,350 $71,324 
(1) The Company expects the deposits made with the Hong Kong Inland Revenue Department (“IRD”) to be refunded upon completion of the audit. See Note 12, "Income Taxes" to the consolidated financial statements for additional details regarding this ongoing tax audit.
(2) Accumulated amortization was $7.1 million and $5.9 million as of March 31, 2024, and June 30, 2023, respectively.
Schedule of Other Current Liabilities
Other current liabilities consisted of the following (in thousands):
March 31, 2024June 30, 2023
Deferred revenue — short-term$18,814 17,911 
Accrued expenses18,708 23,426 
Lease liability— current14,004 14,333 
Warranty accrual10,343 8,745 
Accrued compensation and benefits6,472 7,330 
Customer deposits1,656 1,211 
Reserve for sales returns4,480 4,999 
Inventory received not billed53,298 56,862 
Other payables14,743 7,028 
Total$142,518 $141,845 
Schedule of Other Long-Term Liabilities
Other long-term liabilities consisted of the following (in thousands):
March 31, 2024June 30, 2023
Deferred revenue — long-term$11,131 $7,774 
v3.24.1.1.u2
ACCRUED WARRANTY (Tables)
9 Months Ended
Mar. 31, 2024
Product Warranties Disclosures [Abstract]  
Schedule of Warranty Obligations
Warranty obligations, included in other current liabilities, were as follows (in thousands):
 Nine Months Ended March 31,
 20242023
Beginning balance$8,745 $6,394 
Accruals for warranties issued during the period9,463 8,344 
Changes in liability for pre-existing warranties during the period887 206 
Settlements made during the period(8,752)(7,001)
Ending balance$10,343 $7,943 
v3.24.1.1.u2
DEBT (Tables)
9 Months Ended
Mar. 31, 2024
Debt Disclosure [Abstract]  
Schedule of Debt
The Company's debt consisted of the following (in thousands):
March 31, 2024June 30, 2023
Initial Term Loan Facility - short term$25,000 $25,000 
First Amendment Term Loan Facility - short-term12,500 12,500 
Debt issuance costs, net(992)(992)
Total Debt - short term36,508 36,508 
Initial Term Loan Facility - long term400,000 418,750 
First Amendment Term Loan Facility - long-term225,000 234,375 
Revolving Facility - long term215,000 390,000 
Debt issuance costs, net(995)(1,744)
Total Debt - long term$839,005 $1,041,381 
Schedule of Estimated Debt and Interest Payment Obligations
The following table summarizes the Company’s estimated debt and interest payment obligations as of March 31, 2024, for the remainder of fiscal 2024 and future fiscal years (in thousands):
2024 (remainder)
2025202620272028ThereafterTotal
Debt payment obligations$9,375 $37,500 $830,625 $— $— $— $877,500 
Interest and other payments on debt payment obligations (1)
16,227 63,384 45,624 — — — 125,235 
Total$25,602 $100,884 $876,249 $— $— $— $1,002,735 
(1) Interest payments are calculated based on the applicable rates and payment dates as of March 31, 2024. Although our interest rates on our debt obligations may vary, we have assumed the most recent available interest rates for all periods presented.
v3.24.1.1.u2
LEASES (Tables)
9 Months Ended
Mar. 31, 2024
Leases [Abstract]  
Schedule of Lease Costs
The following table summarizes our lease costs for the three and nine months ended March 31, 2024 and 2023 (in thousands):
Financial Statement ClassificationThree Months Ended March 31,Nine Months Ended March 31,
2024202320242023
Operating lease costs:
Fixed lease costsOperating expenses$2,892 $2,761 $8,684 $8,287 
Fixed lease costsCost of revenues1,126 1,010 2,951 2,975 
Variable lease costsOperating expenses229 234 555 388 
Variable lease costsCost of revenues44 149 511 305 
Total lease costs$4,291 $4,154 $12,701 $11,955 
Schedule of Undiscounted Future Fixed Payment Obligations Under Recognized Operating Leases and Reconciliation of Operating Lease Liabilities
The following table shows the Company’s undiscounted future fixed payment obligations under the Company’s recognized operating leases and a reconciliation to the operating lease liabilities as of March 31, 2024:
Remainder of Fiscal 2024
$4,012 
Fiscal 2025
14,605 
Fiscal 2026
10,299 
Fiscal 2027
6,213 
Fiscal 2028
4,825 
Thereafter15,950 
Total future fixed operating lease payments$55,904 
Less: Imputed interest$4,406 
Total operating lease liabilities$51,498 
Weighted-average remaining lease term - operating leases6 years
Weighted-average discount rate - operating leases3.2 %
v3.24.1.1.u2
SHARE-BASED COMPENSATION (Tables)
9 Months Ended
Mar. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock-Based Compensation Expense
The following table shows total share-based compensation expense included in the consolidated statements of operations and comprehensive income for the three and nine months ended March 31, 2024 and 2023 (in thousands):

 Three Months Ended March 31,Nine Months Ended March 31,
 2024202320242023
Cost of revenues$44 $24 $113 $47 
Research and development1,272 942 3,567 2,524 
Sales, general and administrative348 280 991 823 
1,664 1,246 $4,671 $3,394 
Schedule of Activity of RSUs
The following table summarizes the activity of the RSUs made by the Company:

Number of SharesWeighted Average Grant Date Fair Value Per Share
Non-vested RSUs, June 30, 2023
62,948 $256.78 
RSUs granted60,309 $149.97 
RSUs vested(21,972)$238.65 
RSUs canceled(1,408)$293.51 
Non-vested RSUs, March 31, 2024
99,877 $195.76 
v3.24.1.1.u2
SEGMENT INFORMATION, REVENUES BY GEOGRAPHY AND SIGNIFICANT CUSTOMERS (Tables)
9 Months Ended
Mar. 31, 2024
Segment Reporting [Abstract]  
Schedule of Revenues by Product
Revenues by product type are as follows (in thousands, except percentages):
 Three Months Ended March 31,Nine Months Ended March 31,
 2024202320242023
Enterprise technology$414,345 84 %$373,573 82 %$1,185,932 83 %$1,217,279 84 %
Service provider technology78,652 16 %84,200 18 %235,097 17 %232,148 16 %
Total revenues$492,997 100 %$457,773 100 %$1,421,029 100 %$1,449,427 100 %
Schedule of Revenues by Geography
Revenues by geography based on customer’s ship-to destinations were as follows (in thousands, except percentages):
 Three Months Ended March 31,Nine Months Ended March 31,
 2024202320242023
North America (1)
$242,511 49 %$230,741 50 %$693,154 49 %$683,907 47 %
Europe, the Middle East and Africa (“EMEA”)200,666 41 %173,262 38 %546,010 38 %568,502 39 %
Asia Pacific26,459 %26,880 %95,815 %116,158